Searched for
R SANKARAIAH
Stocks in the news: Mindtree, Hotel Leelaventure, RCom, L&T and Jet AirwaysGST Council may consider lowering of GST rates for the real estate sector.- Jubilant Life Sciences raises $300 million via bond issuanceThe issue is said to have attracted high quality investors including private banks and asset management companies such as Fidelity and HSBC...
- Jubilant Life posts net loss of Rs 63.53 crore in Q4Jubilant Life Sciences today reported a consolidated net loss of Rs 63.53 crore for the fourth quarter ended March 31.
- To get additional revenues of $90 mn from new plant in Gujarat SEZ: Jubilant Life SciencesR Sankaraiah, Executive Director, Finance, Jubilant Life Sciences, talks about the company's new plan in Gujarat SEZ and the revenues expec...
- Global consolidation hits Indian contract drug manufacturing cosMany global research firms, such as Pfizer, GSK and Merck, have announced massive cost-cutting measures, including expenses in R&D.
- FCCB repayments may test Indian cosIndia Inc is bracing up for repayment of foreign currency convertible bonds (FCCBs) as they fast approach the maturity or conversion dates ...
- Jubilant Life Sciences Q2 net up 42 per cent to Rs 82 croreJubilant Life Sciences today said its consolidated net profit rose by 41.37 per cent to Rs 82 crore for the second quarter ended September ...
- Jubilant wants remaining stake of Cadista HoldingsJubilant Life Sciences (formerly Jubilant Organosys) has offered to buy 17.6% stake in US-based Cadista Holdings Inc for Rs 28 crore to mak...
- Jubilant Organosys net up at Rs 137 crJubilant Organosys rode revenues from three manufacturing contracts and improved sales of key inputs to post a consolidated net profit of R...
- Jubilant to hive off non-core businessPharmaceutical company Jubilant Organosys is demerging its non-core business - agri and performance polymer - into a separate subsidiary to...
- Cos may land a windfall from FCCB buybacksDuring the first nine months of the last fiscal, firms following Accounting Standard 11 had written off heavy mark-to-market losses towards...
- Jubilant Organosys plans to buyback its FCCBChemicals and drugmaker Jubilant Organosys is planning to buyback its foreign currency convertible bonds (FCCB).
Load More- To get additional revenues of $90 mn from new plant in Gujarat SEZ: Jubilant Life Sciences
